STADA: Final financial figures for 2005 confirm robust growth course

STADA reports to achieve especially pleasing sales increases in 2005 in Belgium (by 43% to EUR 93.6 million), in France (by 31% to EUR 70.7 million), in Italy (by 27% to EUR 94.6 million), in Austria (by 27% to EUR 10.4 million) and in Spain (by 19% to EUR 53.0 million). In Russia, following the acquisition of Nizhpharm at the beginning of the year 2005, STADA was able to post sales of EUR 56.6 million. In local currency, as compared to the sales achieved by the former owners in 2004, Nizhpharm was thereby able to raise sales in Russia by 40%.